Children’s Hospital Administers First Commercially Available Gene Therapy for Hemophilia B

Children’s Hospital Administers First Commercially Available Gene Therapy for Hemophilia B
Image

Supported through educational grants from BioMarin, CSL Behring, Pfizer Inc., Roche, and Spark Therapeutics

Essential SSL